Frits Michiels
- Life Sciences
- European Patent Attorney
- Dutch Patent Attorney
- Senior Associate
“To explore, together with a client, how the best IP protection can be obtained is for me the logical next step after an invention has been made.”
Frits Michiels has had an extensive scientific career in both knowledge institutes and biotech companies. From 2004, he was employed as IP manager at Galapagos Genomics BV and subsequently also at other Dutch biotech startups. He has worked for V.O. since 2006.
News
The consequences of the Nagoya Protocol
The Nagoya Protocol is highly relevant for the Dutch seed culture sector. But the content of the protocol is far from easy to understand. IP Leads summarises the main provisions for you and the most important consequences.Continue reading
No happy ending for a pharmaceutical company in a case involving a Native American tribe
In the case known as Mohawk tribe versus Mylan, the US Federal Circuit Court of Appeals ruled that patent holders cannot shield themselves from an “inter partes review” of a patent by assigning that patent to a Native American tribe. Ironically enough, this is due to the fact that the decision handed down by the […]Continue reading
Does the new law for the protection of trade secrets offer sufficient protection?
On 9 June, the new law for the protection of trade secrets came into force (based on European Directive 2016/943/EU). On the basis of the law, it is possible to take action against the illegal acquisition, use and disclosure of trade secrets. If a trade secret is misused, the holder can bring various actions based […]Continue reading